GRIFOLS | GRF - Current Liabilities


GRIFOLS reported EUR2.24B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Alcon AG USD 3B 45M Mar/2026
Almirall EUR 323.65M 26.99M Jun/2026
Amadeus IT EUR 3.56B 532.7M Jun/2026
Amarin USD 164.2M 15.45M Jun/2026
argenx SE USD 1.58B 254.81M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
Bayer EUR 33.46B 875M Mar/2026
Cie Automotive EUR 1.92B 8.97M Dec/2025
Demant DKK 7.42B 1.63B Dec/2025
Ence Energia y Celulosa EUR 415.1M 19.93M Mar/2026
Essilor EUR 12.64B 490M Jun/2026
Ferrovial EUR 5.69B 778M Jun/2026
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Genmab DKK 1.43B 686M Dec/2025
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GRIFOLS EUR 2.24B 112M Jun/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Inditex EUR 12.47B 2.29B Mar/2026
Lakefront Biotherapeutics EUR 100.42M 52.44M Mar/2026
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Philips EUR 7.42B 8M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
UCB EUR 4.4B 470M Dec/2025
Viscofan EUR 467.46M 29.97M Jun/2026